FDA Action Plan Will Enhance Demographic Data in Trials

Clinical Trials Advisor
A A
The FDA has released an action plan aimed at encouraging more diverse patient participation in drug and medical device clinical trials.

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00